Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12415
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGrossmann, Mathisen
dc.date.accessioned2015-05-16T02:06:41Z
dc.date.available2015-05-16T02:06:41Z
dc.date.issued2014-10-01en
dc.identifier.citationThe Journal of Clinical Endocrinology and Metabolism; 99(10): 3625-8en
dc.identifier.govdoc25279574en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/12415en
dc.language.isoenen
dc.subject.otherAndrogen Antagonists.adverse effectsen
dc.subject.otherBody Mass Indexen
dc.subject.otherHumansen
dc.subject.otherImmunoglobulin Fc Fragments.adverse effectsen
dc.subject.otherMaleen
dc.subject.otherMuscle, Skeletal.drug effectsen
dc.subject.otherMyostatin.antagonists & inhibitorsen
dc.subject.otherProstatic Neoplasms.drug therapyen
dc.subject.otherRecombinant Fusion Proteins.adverse effectsen
dc.titleMyostatin inhibition: a new treatment for androgen deprivation-induced sarcopenia?en
dc.typeJournal Articleen
dc.identifier.journaltitleThe Journal of Clinical Endocrinology and Metabolismen
dc.identifier.affiliationDepartment of Medicine Austin Health, University of Melbourne, and Endocrine Unit, Austin Health, Heidelberg, Victoria 3052, Australiaen
dc.identifier.doi10.1210/jc.2014-3290en
dc.description.pages3625-8en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/25279574en
dc.type.austinJournal Articleen
local.name.researcherGrossmann, Mathis
item.languageiso639-1en-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
crisitem.author.deptEndocrinology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

18
checked on Nov 5, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.